FoundationOne Liquid CDx
FDA Approves Foundation Medicine’s Liquid Biopsy Test as Companion Diagnostic for Novartis’ Tabrecta
2021-07-18
Genomic Profiling Reveals Multiple Resistance Mechanisms of Cancers Against KRAS Inhibitors
2021-06-25
FMI Empowers its Genomic Cancer Testing by Licensing TwinStrand’s Duplex Sequencing Technology
2020-11-18
Foundation Medicine’s Liquid Biopsy Test Bags FDA Approval for Eighth Indication as Companion Diagnostic
2020-11-10
FMI’s Liquid Biopsy Test Adds 3 Companion Diagnostic Indications for Advanced Ovarian, Breast and Lung Cancers
2020-10-30
LATEST
University of Pittsburgh Study Finds Flu Vaccines Prevent Up to 41.5 Percent of Infections in Simulated Communities
2025-07-19
Pharmacist-Led Initiatives Boost Pneumococcal Vaccine Uptake Among Older Adults Through Education and Direct Immunization Services
2025-07-19
Study Finds Agricultural Dust Exposure Alters Gut Microbiota and Weakens Intestinal Barrier in Mice
2025-07-19
Biotech Leaders Urge FDA to Reject Conservative Report Criticizing Mifepristone Safety Profile
2025-07-19